What is WOK's dilution risk score?

WOK has a latest available DilutionScore record of 45/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for WOK, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for WOK?

DilutionWatch tracks 25 SEC filing types for WOK including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect WOK shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For WOK, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for WOK tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for WOK. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

WOK Dilution Risk Score: 45/100 (component-limited)

Score Breakdown

📋 Offering Ability

40

💰Cash Runway—

📊 Float Risk

100

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 15%

🔄 Reverse Split model est. 30%

• 50-day avg $1.20 approaching $1 threshold

🔔 Track WOK — Get forecast alerts →

Market Data

Market Cap$122.3K

Shares Outstanding14.59M

Float1.22M

Cash$4.09M

Debt$6.39M

Short InterestN/A

Institutional Holdings

3 institutional holders · 204 shares

#1 North Star Investment Management Corp 200 shares

#2 Caitong International Asset Management Co., Ltd 3 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest210.3K

Days to Cover1.4

% of Float17.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

4 INSIDER TRANSACTION 2026-06-23

4 INSIDER TRANSACTION 2026-06-17

4 INSIDER TRANSACTION 2026-06-16

3 FORM3 2026-06-12

4 INSIDER TRANSACTION 2026-06-12

Full SEC filing analysis available with free account →

Recent News

WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026 GlobeNewswire · Jun 16

WORK Medical Technology Group Is Trending Overnight — Here's Why WOK Stock Surge Yahoo Finance · May 13

AI Healthcare and BioToken Partnership Expands WORK Medical’s (WOK) Digital Asse Yahoo Finance · May 11

Factual WOK Dilution Snapshot

WORK Medical Technology Group LTD (WOK) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for WOK: 4 on 2026-06-23; 4 on 2026-06-17; 4 on 2026-06-16.
Score coverage note: Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.

More Research for WOK

WOK FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

WOK — WORK Medical Technology Group LTD Dilution Risk Tracker